cytarabine

Type: Keyphrase

Name: cytarabine

First reported May 23 2013 - Updated May 23 2013 - 1 reports

Intensified, Liposomal Anthracycline-Based Chemo Regimen for Children with Leukemia May Offer High Survival Rates Without Added Heart Toxicity

/PRNewswire-USNewswire/ -- Treating pediatric leukemia patients with a liposomal formulation of anthracycline-based chemotherapy at a more intense-than-standard dose during initial treatment may result in high survival rates without causing any added ... [Published TickerTech.com - May 23 2013]

Entities: idarubicin, Patient, liposomal

First reported May 17 2013 - Updated May 17 2013 - 1 reports

Seeking calm on the cancer ward

When people choose to have their leukemia treated aggressively, it's a big commitment, more so than for almost any other cancer. With this therapy — three days of the drug daunorubicin, which comes in a reddish color so distinctive that one of my patients, ... [Published Health Leaders - May 17 2013]

Entities: Cancer, daunorubicin, cytarabine

First reported May 16 2013 - Updated May 16 2013 - 1 reports

Seeking Calm on the Cancer Ward

Darren Hauck for The New York Times On the shores of Lake Michigan.When people choose to have their leukemia treated aggressively, it’s a big commitment, more so than for almost any other cancer.With this therapy — three days of the drug daunorubicin, ... [Published New York Times - May 16 2013]

Entities: Leukaemia, Cancer, Patient, daunorubicin, cytarabine

First reported May 14 2013 - Updated May 14 2013 - 1 reports

Homoharringtonine-based regimen proves effective for leukemia treatment: study

A five-year clinical study has found that a regimen involving a plant-based medicine was effective in the treatment of acute myeloid leukaemia (AML), researchers said Tuesday. The study followed the treatment of 620 AML patients from across China, and ... [Published Individual.com - May 14 2013]

Entities: Leukaemia, homoharringtonine, cytarabine

First reported May 14 2013 - Updated May 14 2013 - 1 reports

Survey: Drug Shortages May Weaken Cancer Care

Shortages of cancer drugs continue to take a toll on patient care, increasing drug errors and costs, and leading in some cases to the purchase of short-supply products from “gray-market” suppliers, according to results of a new survey of oncology pra ... [Published Pharmacy Practice News - May 14 2013]

Entities: Drugs, doxorubicin, Cancer, leucovorin, liposomal

First reported May 09 2013 - Updated May 10 2013 - 1 reports

Sunesis Pharmaceuticals Inc

Sunesis Pharmaceuticals Reports First Quarter Financial Results and Recent Highlights

Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today reported financial results for the quarter ended March 31, 2013. Loss from operations for the three months ended March 31, 2013 was $7.8 million. As of March 31, 2013, cash, cash equivalents and marketable ... [Published Individual.com - May 09 2013]

Entities: Sunesis Pharmaceuticals Inc, Patient, cytarabine, Acute Myeloid Leukemia, Kinase

First reported May 09 2013 - Updated May 09 2013 - 1 reports

"Compositions of Botanical Extracts for Cancer Therapy" in Patent Application Approval Process

The following quote was obtained by the news editors from the background information supplied by the inventors: "Any one individual is at risk of developing cancer. The occurrence of cancer increases with aging over a life time ('lifetime risk'). For ... [Published Pharmacy Choice - May 09 2013]

Entities: Cancer, Salvia Miltiorrhiza, Ganoderma, antineoplastic

First reported May 08 2013 - Updated May 08 2013 - 1 reports

Star honours spirit of Irish girls

HOLLYWOOD star Kevin Spacey has congratulated two young Irish volunteers as they were honoured on the world stage for their selfless work helping others.Orla Jackman (15), from Tullow, Co Carlow, and Leigha Coade (17), from Armagh, joined other teenage ... [Published Irish Independent - May 08 2013]

Entities: Orla (India), cytarabine, John Strangfeld, Cystic Fibrosis Foundation

First reported May 04 2013 - Updated May 04 2013 - 1 reports

Pediatric AML: Genotype Predicts Treatment-Related Toxicity in African American and Asian Patients

ATLANTA—A specific genetic marker may be associated with reduced toxicity from chemotherapy in African-American and Asian children with acute myeloid leukemia (AML), according to research reported here at the American Society of Hematology Annual Meeting ... [Published Oncology Times - May 04 2013]

Entities: Patient, African-Americans, Toxicity

First reported Apr 30 2013 - Updated May 01 2013 - 6 reports

Celator Pharma Lines Up $32.5M for New Approach to Leukemia

Doctors have used a standard, first-line drug regimen to treat acute myeloid leukemia for more than 30 years, but Celator Pharmaceuticals Inc . believes it can make this treatment better and extend lives.Celator, which became a public-reporting company ... [Published Dow Jones Financial Information Services - May 01 2013]

Entities: Leukaemia, Celator Pharmaceuticals Inc, daunorubicin, cytarabine, Acute Myeloid Leukemia

First reported Apr 05 2013 - Updated Apr 05 2013 - 1 reports

Investment Research Weekly Roundup including Lo-Q, Amara Mining, Futura Medical,Brainjuicer

OvaScience - OTC:OVSC Update - Ova delivering 04 April 2013 OvaScience has raised $35m to advance its pipeline and support a planned move to NASDAQ in Q213. With pro forma cash of c $60m, the company can now accelerate the development of AUGMENT ... [Published Proactiveinvestors United Kingdom RSS feed - Apr 05 2013]

Entities: Lo-Q PLC, Futura Medical plc, BrainJuicer Group PLC

First reported Mar 21 2013 - Updated Mar 21 2013 - 1 reports

Vosaroxin: A Promising Drug For A Difficult Disease

ByVeziris Ventures: Since initiating its Phase 3 study in AML in December 2010, Sunesis Pharmaceuticals, Inc. ( SNSS ) has been widely followed by the investment community. Over the past two years, the company has been successful in raising roughly ... [Published Healthcare Sector and Stocks Analysis from Seek ... - Mar 21 2013]

Entities: Sunesis Pharmaceuticals Inc, Drugs, Phase III

Quotes

"We look forward to further investigating liposomal daunorubicin as the standard anthracycline induction treatment in future studies" she said

New and Improved Leukemia Rx [Published Daily Rx - 17 hours ago]

"LDL is taken up into cells by a receptor known as the LDL receptor (LDLR); the LDL along with the receptor is endocytosed and transported into the cells in endosomes. The endosomes become acidified and this releases the LDL receptor from the LDL; the LDL receptor recycles to the surface where it can participate in additional uptake of LDL particles. There is a body of evidence that suggests that tumors in a variety of tissues have a high requirement for LDL to the extent that plasma LDLs are depleted. The increased import of LDL into cancerous cells is thought to be duedue to elevated LDL receptors (LDLR) in these tumors. Some tumors known to express high numbers of LDLRs include some forms of leukemia, lung tumors, colorectal tumors and ovarian cancer."

Patent Issued for Acid-Labile Lipophilic Prodrugs of Cancer . . . [Published Equities.com - May 22 2013]

More Content

sort by: Date \| Relevance
New and Improved Leukemia Rx [Published Daily Rx - 17 hours ago]
Intensified, Liposomal Anthracycline-Based Chem... [Published TickerTech.com - May 23 2013]
Patent Issued for Acid-Labile Lipophilic Prodru... [Published Equities.com - May 22 2013]
+ Chinese original Homoharringtonine (HHT) ther... [Published Noodls - May 19 2013]
Cummings Introduces Bill to Reform 'Gray Market... [Published Pharmacy Choice - May 18 2013]
Mundipharma International Limited - Pharmaceuti... [Published TransWorldNews - May 18 2013]
Seeking calm on the cancer ward [Published Health Leaders - May 17 2013]
Seeking Calm on the Cancer Ward [Published New York Times - May 16 2013]
CORRECTING and REPLACING Celator Pharmaceutical... [Published Pharmacy Choice - May 16 2013]
Celator® Pharmaceuticals Announces Business Upd... [Published Reuters - May 15 2013]
Drug Patent Expirations for May 14 2013 [Published Biotech Blog - May 14 2013]
Homoharringtonine-based regimen proves effectiv... [Published Individual.com - May 14 2013]
Survey: Drug Shortages May Weaken Cancer Care [Published Pharmacy Practice News - May 14 2013]
Drug Patent Expirations in May 2013 [Published Biotech Blog - May 13 2013]
Cellceutix Corporation: The Next Generation Of ... [Published Seeking Alpha - May 10 2013]
Sunesis Pharmaceuticals Management Discusses Q1... [Published Seeking Alpha - May 10 2013]
Sunesis Pharmaceuticals Reports First Quarter F... [Published Individual.com - May 09 2013]
"Compositions of Botanical Extracts for Cancer ... [Published Pharmacy Choice - May 09 2013]
Star honours spirit of Irish girls [Published Irish Independent - May 08 2013]
High-Risk MDS: Is Transplant without Induction ... [Published Oncology Times - May 04 2013]
Pediatric AML: Genotype Predicts Treatment-Rela... [Published Oncology Times - May 04 2013]
MRI Interventions' ClearPoint Neuro Interventio... [Published Interest!ALERT - May 03 2013]
Celator Pharma Lines Up $32.5M for New Approach... [Published Dow Jones Financial Information Services - May 01 2013]
Celator offers disruptive approach to chemo tre... [Published MedCity News - May 01 2013]
Celator Pharmaceuticals INKS $32.5M [Published PE Hub News - May 01 2013]
VCs provide $40M to finance Celator's pivotal P... [Published FierceBiotech - May 01 2013]
Celator Pharmaceuticals Raises $32.5 Million [Published Citybizlist - May 01 2013]
Celator® Pharmaceuticals Raises $32.5 Million C... [Published Yahoo! Finance - Apr 30 2013]
Celator® Pharmaceuticals Raises $32.5 Million C... [Published Business Wire - Apr 30 2013]
The Benefits Of Using Liposome Preparations [Published Article Motron - Apr 22 2013]

sort by: Date \| Relevance
Drug Patent Expirations for May 14 2013 [Published Biotech Blog - May 14 2013] Copyright © thinkBiotech If your reader cannot render the information below, go tohttp://www.DrugPatentWatch.com/innovation to see the latest expirationsbody { font-family:Calibri, tahoma, arial,sans-serif;}table { font-size:12px; font-family:Calibri, ...
Drug Patent Expirations in May 2013 [Published Biotech Blog - May 13 2013] Copyright © thinkBiotech Drug Patent Expirations for May 2013TradenameApplicantGeneric NamePatent NumberPatent Expiration HUMALOG PEN Lilly insulin lispro recombinant 5,514,646 May 7, 2013 GEMZAR Lilly gemcitabine hydrochloride 5,464,826*PED ...
Human medicines European Public Assessment Repo... [Published Pending EC decisions and European Public Assess ... - Dec 18 2012]